Wei Liang
Director, Development Sciences @ Bambusa Therapeutics
About
• 14 years of post-Ph.D. experience in immuno-oncology, oncology, inflammation and autoimmune disease areas • Experienced in drug discovery and development, including but not limited to preclinical research, IND-enabling nonclinical studies, regulatory submissions, and bioanalytical activities • Team-leading and hand-on execution roles across biotech and CRO environments
United States
San Diego
Biotechnology
Nonclinical development, Bispecific antibody, Drug Development, Neutralizing antibody assay (NAb), Risk Assessment, Failure Mode and Effects Analysis (FMEA), Bioanalysis, Pharmacokinetics, Anti-drug antibody (ADA), Design of Experiments (DOE), Upstream BioProcess development, Cell Therapy, Cancer Immunotherapy, Recombinant protein expression in bacteria, In Vivo, Cytotoxicity, Analytical assay qualification, Enzyme potency assays, Transduction, Contract Research Organization (CRO)
Experience
Director, Development Sciences
Bambusa Therapeutics
Preclinical and nonclinical development of bispecific antibody assets for inflammatory and autoimmune diseases
Associate Director, Research and Development
Ansun Biopharma, Inc.
San Diego, California, United States
• De novo invention and development of Ansun's OptiALLO CAR γδ T cell therapy technology • Led/co-led the cell therapy R&D programs • Managed bioanalytical (assays and clinical sample analyses) for a biologic asset (DAS181) in a Ph3 trial • Supervised Scientists and Research Associates
Associate Director I; Study Director
BioDuro
San Diego, California, United States
• Leader of BioDuro Oncology San Diego • Managed in vitro and in vivo pharmacology and tolerability studies, to support preclinical development and IND-filing of sponsors' small molecule therapeutics, antibodies, TCE and CAR-T cell therapies • Team hiring; Supervised Scientists and Research Associates • Scientific engagement and support for domestic and international sponsors
Postdoctoral Scholar
UC San Diego
Dr Napoleone Ferrara's laboratory • Discovery of a novel tumor-supporting mechanism of neutrophils • Identification of a pharmacological strategy for targeting the pro-tumoral neutrophils • Discovery of novel angiogenesis mechanisms
Postdoctoral Fellow
City of Hope Comprehensive Cancer Center
Duarte, CA
Dr Richard Jove's laboratory • Identified the protumoral roles of Src family kinases in the tumor microenvironment • Defined the synergistic anticancer effects of adoptive T-cell immunotherapy in combination with tumor angiogenesis inhibitors
Education
University of Science and Technology of China
Biology, General
Wei Liang's Contact Information
Phone
Find the Right Leads
Find Verified Contact Data
What LeadContact does well
Find verified emails, phone numbers, and decision-makers with 98% accuracy.
Find Leads
Find the right people by company, role, industry, location, and more.
925M+ professional profiles
Find Emails
Access verified email addresses for your target contacts.
657M+ emails
Find Phone Numbers
Get cross-validated phone data from multiple top sources.
239M+ phone numbers
More Accurate. Lower Cost.
Find contact data in 1 tool with 98% accuracy
LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.
Great conversations start with the right contact.
It’s time to find yours.